Biogen Inc banner

Biogen Inc
NASDAQ:BIIB

Watchlist Manager
Biogen Inc Logo
Biogen Inc
NASDAQ:BIIB
Watchlist
Price: 202.28 USD -0.33%
Market Cap: $29.9B

Wall St Price Targets

BIIB Price Targets Summary
Biogen Inc

Wall Street analysts forecast BIIB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BIIB is 225.19 USD with a low forecast of 151.5 USD and a high forecast of 315 USD.

Lowest Forecast
Price Target
151.5 USD
25% Downside
Average Forecast
Price Target
225.19 USD
11% Upside
Highest Forecast
Price Target
315 USD
56% Upside
Biogen Inc Competitors:
Price Targets
LAND
Gladstone Land Corp
41% Upside
ARDX
Ardelyx Inc
228% Upside
AREC
American Resources Corp
220% Upside

Revenue
Forecast

5% / Year
Past Growth
2% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
5% / Year
Past Growth
2% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 8 years is 2%.

Gross Profit
Forecast

3% / Year
Past Growth
3% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
3% / Year
Past Growth
3% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 13 years, the compound annual growth rate for Gross Profit has been 3%. The projected CAGR for the next 8 years is 3%.

Operating Income
Forecast

2% / Year
Past Growth
6% / Year
Estimated Growth
Estimates Accuracy
-8%
Average Miss
2% / Year
Past Growth
6% / Year
Estimated Growth
Estimates Accuracy
-8%
Average Miss

Over the last 13 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 8 years is 6%.

Pre-Tax Income
Forecast

-1% / Year
Past Growth
29% / Year
Estimated Growth
Estimates Accuracy
-15%
Average Miss
-1% / Year
Past Growth
29% / Year
Estimated Growth
Estimates Accuracy
-15%
Average Miss

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been -1%. The projected CAGR for the next 3 years is 29%.

Net Income
Forecast

-1% / Year
Past Growth
14% / Year
Estimated Growth
Estimates Accuracy
-18%
Average Miss
-1% / Year
Past Growth
14% / Year
Estimated Growth
Estimates Accuracy
-18%
Average Miss

Over the last 13 years, the compound annual growth rate for Net Income has been -1%. The projected CAGR for the next 8 years is 14%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is BIIB's stock price target?
Price Target
225.19 USD

According to Wall Street analysts, the average 1-year price target for BIIB is 225.19 USD with a low forecast of 151.5 USD and a high forecast of 315 USD.

What is the Revenue forecast for Biogen Inc?
Projected CAGR
2%

Over the last 13 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 8 years is 2%.

What is the Gross Profit forecast for Biogen Inc?
Projected CAGR
3%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 3%. The projected CAGR for the next 8 years is 3%.

What is the Operating Income forecast for Biogen Inc?
Projected CAGR
6%

Over the last 13 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 8 years is 6%.

What is the Pre-Tax Income forecast for Biogen Inc?
Projected CAGR
29%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been -1%. The projected CAGR for the next 3 years is 29%.

What is the Net Income forecast for Biogen Inc?
Projected CAGR
14%

Over the last 13 years, the compound annual growth rate for Net Income has been -1%. The projected CAGR for the next 8 years is 14%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett